Work

CTEP #8342 autophagy modulation with antiangiogenic therapy: A phase I trial of sunitinib (Su) and hydroxychloroquine (HCQ).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.2553

Authors: Nataliya Melnyk, Xiaoqi Xie, Danny Ju Yong Koh, Megha Rajpal, Rebecca Anne Moss, Darlene Gibbon, James M. Cleary, Minh-Thu Tran, Pamela Scott, Mark N. Stein, Antoinette R. Tan, Shari Adams, Diana C. Lindquist, Pamela Jo Harris, Naoko Takebe, Hongxia Lin, Joseph Aisner, Eileen White, Robert S. DiPaola, Janice M. Mehnert

Institutions: Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Dana-Farber Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Autophagy in Disease and Therapy

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2800633459

Cites:

Cited by: 5

Related to: 10